NCT00283114 2014-12-18A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromeSeagen Inc.Phase 1 Completed82 enrolled
NCT00502112 2011-10-12A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)Seagen Inc.Phase 1 Completed13 enrolled